IGF-IR Monoclonal Antibody

This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.

The IGF-IR Monoclonal Antibody is a highly specialized product designed to target and bind to the insulin-like growth factor receptor (IGF-IR) present on the surface of cells. This antibody is produced using advanced monoclonal antibody technology, ensuring high specificity and affinity for the IGF-IR target.

The IGF-IR Monoclonal Antibody is a valuable tool for researchers and clinicians studying the role of IGF-IR in various biological processes, including cell growth, differentiation, and survival. It can be used in a variety of applications, including Western blotting, immunoprecipitation, and immunohistochemistry.

This product is manufactured to the highest quality standards, ensuring consistent performance and reproducibility. It is supplied in a convenient format, with a range of sizes available to suit different experimental needs.

Overall, the IGF-IR Monoclonal Antibody is a reliable and effective tool for investigating the function of IGF-IR in biological systems, and is an essential component of any research or clinical laboratory focused on this area of study.